Showing 801 - 820 results of 33,911 for search '(( 50 ((a decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 2 fold decrease ))', query time: 0.96s Refine Results
  1. 801
  2. 802
  3. 803
  4. 804
  5. 805
  6. 806
  7. 807
  8. 808
  9. 809
  10. 810

    Complete data. by Jan Víteček (11434774)

    Published 2024
    “…A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”
  11. 811

    Fig 4 - by Jan Víteček (11434774)

    Published 2024
    “…A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”
  12. 812

    Fold decrease in virulence gene expression of <i>Salmonella in vivo</i> and <i>in vitro</i><sup>a</sup>. by Xiaojian Yang (295141)

    Published 2014
    “…Values were expressed as mean ± standard error. The fold-change of target gene was analyzed using the 2<sup>−ΔΔCt</sup> method. …”
  13. 813
  14. 814

    The mean <i>z</i>-coordinate error decreasing percentages (%) of SSI-RIK compared to EM-SFM, CSF and RIK, when the sequence sizes vary from 15 to 50 with an equal interval 5. by Ya-Ping Wang (44525)

    Published 2015
    “…<p>The mean <i>z</i>-coordinate error decreasing percentages (%) of SSI-RIK compared to EM-SFM, CSF and RIK, when the sequence sizes vary from 15 to 50 with an equal interval 5.…”
  15. 815
  16. 816

    Exposure to EtBr decreases mtRNA in rat striatal co-cultures, purified neuronal cultures, and astrocytes. by Emily Booth Warren (4276333)

    Published 2017
    “…<p>(A-C) Log2-fold decrease in mtRNA expression after EtBr treatment assayed with RNASeq, in (A) NECos, (B), pure neuronal cultures, and (C) astrocytes. …”
  17. 817
  18. 818
  19. 819

    Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  20. 820